AZO vs STRO
AutoZone Inc (AZO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AZO and STRO stock pages for the full models.
Not investment advice.